Replies to post #19102 on NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

Forgive me, but wouldn't these companies be shareholder's too? If the payment situation for some 90,000 patients isn't going to be good for NWBT, one would expect it would eventually hurt the stock price? If it hurts the stock price, Toucan and Cognate have more to lose, than they would on the payout for services rendered, at least before the scale up point anyway. This leads me to conclude, Linda will be thinking in the best interest of us shareholders, as they will have the most to gain as well. But, I thought that she would anyway, well before applying rational reasoning. :)

Of course they want they stock price to escalate, that's why they are trucking it out in huge proportions. BUT as with all Biotech's, the risk for failure is huge so why not build another company and profit structure negate that NWBO risk? The fact that people will be happy with the scraps if we succeed......I don't even have words for it. The company has a responsibility to all shareholders and we should expect that. We should expect that our return on investment is considered as much as those that have invested much more.